News of Note—Indian vaccine controversy, Genocea and more

newspapers
In this week's news of note, Genocea named two new executives. (Pixabay)

Here is some other vaccine news of note for the week:

> Officials in India inadvertently distributed a batch of tainted polio vaccines, but the WHO said the risk of infection for children was "minimal." Reuters article

> Genocea appointed Thomas Davis as its chief medical officer and Derek Meisner as its general counsel. Release

> OncBioMune kicked off a phase 2 trial of a candidate vaccine to treat prostate cancer. Release

> BlueWIllow Biologics picked up a Small Business Innovation Research grant from the National Institutes of Health to work on a chlamydia vaccine. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.